APOL1 抗体

Halfter, Moes, Asgeirsson, Halfter, Oertle, Melo Herraiz, Plodinec, Jenoe, Henrich: "Diabetes-related changes in the protein composition and the biomechanical properties of human retinal vascular basement membranes." in: PLoS ONE, Vol. 12, Issue 12, pp. e0189857, (2018) (PubMed).

Johnstone, Shegokar, Nihalani, Rathore, Mallik, Ashish, Zare, Ikizler, Powar, Holzman: "APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis." in: PLoS ONE, Vol. 7, Issue 12, pp. e51546, (2013) (PubMed).

Madhavan, OToole, Konieczkowski, Ganesan, Bruggeman, Sedor: "APOL1 localization in normal kidney and nondiabetic kidney disease." in: Journal of the American Society of Nephrology : JASN, Vol. 22, Issue 11, pp. 2119-28, (2011) (PubMed).

Vanhollebeke, Nielsen, Watanabe, Truc, Vanhamme, Nakajima, Moestrup, Pays: "Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Issue 10, pp. 4118-23, (2007) (PubMed).

Pérez-Morga, Vanhollebeke, Paturiaux-Hanocq, Nolan, Lins, Homblé, Vanhamme, Tebabi, Pays, Poelvoorde, Jacquet, Brasseur, Pays: "Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes." in: Science (New York, N.Y.), Vol. 309, Issue 5733, pp. 469-72, (2005) (PubMed).

Albert, Duchateau, Deeb, Pullinger, Cho, Heilbron, Malloy, Kane, Brown: "Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL." in: Journal of lipid research, Vol. 46, Issue 3, pp. 469-74, (2005) (PubMed).